Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy W M Cheng

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Heart Disease (Hagerstown, Md.)|April 26, 2003
BosentanJudy W M Cheng
Heart Disease (Hagerstown, Md.)|May 25, 2002
Nesiritide: review of clinical pharmacology and role in heart failure managementJudy W M Cheng
Clinical Therapeutics|December 28, 2002
Fondaparinux: a new antithrombotic agentJudy W M Cheng
The Annals of Pharmacotherapy|March 13, 2008
Vernakalant in the management of atrial fibrillationJudy W M Cheng
Clinical Therapeutics|July 25, 2006
A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combinationJudy W M Cheng
Expert Opinion on Pharmacotherapy|August 2, 2002
Pharmacotherapeutic options for the management of myocardial infarctionJudy W M Cheng
Clinical Therapeutics|April 28, 2009
Nebivolol: a third-generation beta-blocker for hypertensionJudy W M Cheng
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 23, 2010
New and emerging antiarrhythmic and anticoagulant agents for atrial fibrillationJudy W M Cheng
The Annals of Pharmacotherapy|September 21, 2006
Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular eventsJudy W M Cheng
Clinical Therapeutics|April 24, 2012
Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromesJudy W M Cheng
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Heart Disease (Hagerstown, Md.)|April 26, 2003
BosentanJudy W M Cheng
Heart Disease (Hagerstown, Md.)|May 25, 2002
Nesiritide: review of clinical pharmacology and role in heart failure managementJudy W M Cheng
Clinical Therapeutics|December 28, 2002
Fondaparinux: a new antithrombotic agentJudy W M Cheng
The Annals of Pharmacotherapy|March 13, 2008
Vernakalant in the management of atrial fibrillationJudy W M Cheng
Clinical Therapeutics|July 25, 2006
A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combinationJudy W M Cheng
Expert Opinion on Pharmacotherapy|August 2, 2002
Pharmacotherapeutic options for the management of myocardial infarctionJudy W M Cheng
Clinical Therapeutics|April 28, 2009
Nebivolol: a third-generation beta-blocker for hypertensionJudy W M Cheng
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 23, 2010
New and emerging antiarrhythmic and anticoagulant agents for atrial fibrillationJudy W M Cheng
The Annals of Pharmacotherapy|September 21, 2006
Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular eventsJudy W M Cheng
Clinical Therapeutics|April 24, 2012
Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromesJudy W M Cheng
Pageof 6